Literature DB >> 26250532

Patterns and prognostic value of lymph node dissection for resected perihilar cholangiocarcinoma.

Kai Mao1,2,3, Jieqiong Liu3,1,4,5,6, Jian Sun1,2, Jianlong Zhang1,2, Jie Chen1,2, Timothy M Pawlik6, Lisa K Jacobs6, Zhiyu Xiao1,2, Jie Wang1,2.   

Abstract

BACKGROUND AND AIM: Lymph node metastasis is a major prognostic factor for perihilar cholangiocarcinoma (PHC). However, prognostic significance of extent of node dissection, lymph node ratio (LNR), and number and location of positive nodes remain unclear. We aimed to evaluate whether node status, LNR, or number or location of positive nodes are independent factors for staging in PHC and to determine the minimum requirements for node examination.
METHODS: The Surveillance, Epidemiology, and End Results database was used to identify 1116 resected PHCs from 1998 to 2008. The correlation between nodal status and survival was analyzed retrospectively.
RESULTS: Lymph node metastasis occurred in 43.4% patients and was an independent predictor for overall survival and cancer-specific survival. No survival benefit was observed for an increasing number of node retrieval in node-positive patients. However, in node-negative patients, ≥13 node dissection was of more survival benefit than 3 ≤ total lymph node count (TLNC) ≤ 12 and TLNC < 3 (5-year overall survival: 52.8% vs 39.7% vs 26.3%, P = 0.001; 5-year cancer-specific survival: 60.6% vs 46.3% vs 30.0%, P = 0.001). No difference in survival between patients with regional and distant node involvement was found. Survival for patients with greater than three positive nodes was significantly worse than that for those with three or less (relative ratio: 1.466, P = 0.001). And patients with LNR > 0.27 also had unfavorable prognosis (relative ratio: 1.376, P = 0.001).
CONCLUSIONS: We determined that to adequately assess nodal status of this life-threatening disease, 13 or more nodes retrieval should be considered. Number of positive nodes and LNR rather than location of metastatic nodes may be defined as parameters for staging of PHC.
© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  hilar cholangiocarcinoma; lymph node ratio; lymph node status; total lymph node count

Mesh:

Year:  2016        PMID: 26250532      PMCID: PMC4732906          DOI: 10.1111/jgh.13072

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  32 in total

1.  Surgical management of hilar cholangiocarcinoma: the Nagoya experience.

Authors:  Hideki Nishio; Masato Nagino; Yuji Nimura
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

2.  Does the extent of lymphadenectomy, number of lymph nodes, positive lymph node ratio and neutrophil-lymphocyte ratio impact surgical outcome of perihilar cholangiocarcinoma?

Authors:  Abdul R Hakeem; Gabriele Marangoni; Stephen J Chapman; Richard S Young; Amit Nair; Ernest L Hidalgo; Giles J Toogood; Judy I Wyatt; Peter A Lodge; K R Prasad
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-09       Impact factor: 2.566

3.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

4.  For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.

Authors:  S Caplin; J P Cerottini; F T Bosman; M T Constanda; J C Givel
Journal:  Cancer       Date:  1998-08-15       Impact factor: 6.860

5.  Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution.

Authors:  Michelle L DeOliveira; Steven C Cunningham; John L Cameron; Farin Kamangar; Jordan M Winter; Keith D Lillemoe; Michael A Choti; Charles J Yeo; Richard D Schulick
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

6.  Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.

Authors:  Sung Gyu Lee; Gi Won Song; Shin Hwang; Tae Yong Ha; Deok Bog Moon; Dong Hwan Jung; Ki Hun Kim; Chul Soo Ahn; Myung Hwan Kim; Sung Koo Lee; Kyu Bo Sung; Gi Young Ko
Journal:  J Hepatobiliary Pancreat Sci       Date:  2009-10-23       Impact factor: 7.027

Review 7.  Hilar cholangiocarcinoma: role of preoperative imaging with sonography, MDCT, MRI, and direct cholangiography.

Authors:  Jin-Young Choi; Myeong-Jin Kim; Jeong Min Lee; Ki Whang Kim; Jae Young Lee; Joon Koo Han; Byung Ihn Choi
Journal:  AJR Am J Roentgenol       Date:  2008-11       Impact factor: 3.959

8.  Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre.

Authors:  Sun Choon Song; Dong Wook Choi; Alfred Wei-Chieh Kow; Seong Ho Choi; Jin Seok Heo; Woo Seok Kim; Min Jung Kim
Journal:  ANZ J Surg       Date:  2012-09-03       Impact factor: 1.872

9.  Surgical treatment of 144 cases of hilar cholangiocarcinoma without liver-related mortality.

Authors:  Norihiko Furusawa; Akira Kobayashi; Takahide Yokoyama; Akira Shimizu; Hiroaki Motoyama; Sin-ichi Miyagawa
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

10.  Lymph node dissection in curative gastrectomy for advanced gastric cancer.

Authors:  Shigeyuki Tamura; Atsushi Takeno; Hirofumi Miki
Journal:  Int J Surg Oncol       Date:  2011-06-14
View more
  17 in total

1.  Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study.

Authors:  Zhimin Yu; Qinghua Liu; Hao Liao; Juanyi Shi; Zhenyu Zhou; Yongcong Yan; Junyao Xu; Chuanchao He; Kai Mao; Jianlong Zhang; Jie Wang; Zhiyu Xiao
Journal:  J Gastrointest Oncol       Date:  2022-04

2.  The influence of 18F-fluorodeoxyglucose positron emission tomography/computed tomography on the N- and M-staging and subsequent clinical management of intrahepatic cholangiocarcinoma.

Authors:  Youpei Lin; Huanhuan Chong; Guohe Song; Chenhao Zhang; Liangqing Dong; Ling Aye; Fei Liang; Shuaixi Yang; Mengsu Zeng; Guangyu Ding; Shu Zhang; Jieyi Shi; Aiwu Ke; Xiaoying Wang; Jian Zhou; Jia Fan; Qiang Gao
Journal:  Hepatobiliary Surg Nutr       Date:  2022-10       Impact factor: 8.265

3.  Defining the Chance of Statistical Cure Among Patients with Extrahepatic Biliary Tract Cancer.

Authors:  Gaya Spolverato; Fabio Bagante; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Emily Winslow; Clifford Cho; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

4.  Conditional probability of long-term survival after resection of hilar cholangiocarcinoma.

Authors:  Stefan Buettner; Georgios A Margonis; Yuhree Kim; Faiz Gani; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2016-04-24       Impact factor: 3.647

5.  External validation study of the 8th edition of the American Joint Committee on Cancer staging system for perihilar cholangiocarcinoma: a single-center experience in China and proposal for simplification.

Authors:  Jian Zhao; Wei Zhang; Jun Zhang; Wen-Jie Ma; Si-Yun Liu; Fu-Yu Li; Bin Song
Journal:  J Gastrointest Oncol       Date:  2021-04

6.  Evaluation of Four Lymph Node Classifications for the Prediction of Survival in Hilar Cholangiocarcinoma.

Authors:  Zhi-Peng Liu; Qing-Yi Zhang; Wei-Yue Chen; Yu-Yan Huang; Yan-Qi Zhang; Yi Gong; Yan Jiang; Jie Bai; Zhi-Yu Chen; Hai-Su Dai
Journal:  J Gastrointest Surg       Date:  2022-01-01       Impact factor: 3.267

7.  Prognostic value of lymph nodes count on survival of patients with distal cholangiocarcinomas.

Authors:  Hua-Peng Lin; Sheng-Wei Li; Ye Liu; Shi-Ji Zhou
Journal:  World J Gastroenterol       Date:  2018-03-07       Impact factor: 5.742

Review 8.  The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis.

Authors:  Lei Liang; Chao Li; Ming-Da Wang; Hao Xing; Yong-Kang Diao; Hang-Dong Jia; Wan Yee Lau; Timothy M Pawlik; Cheng-Wu Zhang; Feng Shen; Dong-Sheng Huang; Tian Yang
Journal:  Int J Clin Oncol       Date:  2021-06-23       Impact factor: 3.402

9.  Prognostic value of resected lymph nodes numbers for Siewert II gastroesophageal junction cancer.

Authors:  Sanchuan Lai; Tingting Su; Xingkang He; Zhenghua Lin; Shujie Chen
Journal:  Oncotarget       Date:  2017-12-20

Review 10.  Extended lymphadenectomy in hilar cholangiocarcinoma: What it will bring?

Authors:  Jian Li; Meng-Hao Zhou; Wen-Jie Ma; Fu-Yu Li; Yi-Lei Deng
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.